Adjuvant immunotherapy and targeted therapy in early and locally advanced resectable lung cancer: expanding treatment tentacles?
Autor: | Evaggelos Fergadis, Amadea Heitmann, Theodore Tsaras, Georgia Hardavella |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2024 |
Předmět: | |
Zdroj: | Breathe, Vol 20, Iss 2 (2024) |
Druh dokumentu: | article |
ISSN: | 1810-6838 2073-4735 20734735 |
DOI: | 10.1183/20734735.0035-2024 |
Popis: | Adjuvant platinum-based chemotherapy has been the main treatment following surgical resection with curative intent in early and locally advanced nonsmall cell lung cancer (NSCLC) albeit with a 5% improvement in 5-year survival rates. Recent advances in biomarkers pave the way for targeted treatments and immunotherapy in a broader spectrum of patients with subsequently improved clinical outcomes. Targeted treatments and immunotherapy have established their place in the adjuvant setting of resected NSCLC. |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |